U.S. Physical Therapy (USPH) Projected to Post Earnings on Wednesday

U.S. Physical Therapy (NYSE:USPH) will likely be posting its Q4 2025 results after the market closes on Wednesday, February 25th. Analysts expect U.S. Physical Therapy to post earnings of $0.67 per share and revenue of $200.0990 million for the quarter. Interested persons can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Thursday, February 26, 2026 at 10:30 AM ET.

U.S. Physical Therapy Stock Down 0.4%

NYSE USPH opened at $86.60 on Wednesday. The stock’s 50 day simple moving average is $82.94 and its 200 day simple moving average is $82.32. U.S. Physical Therapy has a one year low of $62.77 and a one year high of $93.50. The firm has a market cap of $1.32 billion, a PE ratio of 36.39, a price-to-earnings-growth ratio of 3.59 and a beta of 1.30. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.20 and a quick ratio of 1.20.

Analyst Ratings Changes

A number of analysts have recently weighed in on USPH shares. Weiss Ratings restated a “hold (c)” rating on shares of U.S. Physical Therapy in a research note on Wednesday, January 21st. JPMorgan Chase & Co. lowered their price objective on shares of U.S. Physical Therapy from $110.00 to $100.00 and set an “overweight” rating for the company in a research report on Monday, November 24th. Citigroup reiterated a “market outperform” rating on shares of U.S. Physical Therapy in a research report on Monday, December 15th. Finally, Barrington Research reissued an “outperform” rating and issued a $103.00 price target on shares of U.S. Physical Therapy in a report on Monday, January 5th. Four equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, U.S. Physical Therapy has a consensus rating of “Moderate Buy” and an average target price of $105.33.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in USPH. Osaic Holdings Inc. grew its stake in shares of U.S. Physical Therapy by 1.6% during the second quarter. Osaic Holdings Inc. now owns 10,447 shares of the company’s stock worth $817,000 after purchasing an additional 166 shares during the period. Snowden Capital Advisors LLC grew its position in shares of U.S. Physical Therapy by 3.6% during the 2nd quarter. Snowden Capital Advisors LLC now owns 5,600 shares of the company’s stock worth $438,000 after buying an additional 195 shares during the period. Amundi increased its stake in shares of U.S. Physical Therapy by 15.0% in the 3rd quarter. Amundi now owns 2,859 shares of the company’s stock valued at $256,000 after acquiring an additional 373 shares during the last quarter. First Trust Advisors LP increased its stake in shares of U.S. Physical Therapy by 3.7% in the 2nd quarter. First Trust Advisors LP now owns 10,725 shares of the company’s stock valued at $839,000 after acquiring an additional 385 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of U.S. Physical Therapy by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 8,897 shares of the company’s stock valued at $644,000 after acquiring an additional 391 shares during the period.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.